Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger

BACKGROUND AND OBJECTIVE: Trigger finger is a condition in the finger that is locked in flexion or has a heterogeneous movement and is one of the most common causes of pain in the hand; the first line of treatment is the use of corticosteroids. Due to the fact that corticosteroid injection has side...

Full description

Bibliographic Details
Main Authors: S Mohammadi Jami, S Khafri, M Bahrami Feraydoni
Format: Article
Language:English
Published: Babol University of Medical Sciences 2020-03-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Subjects:
Online Access:http://jbums.org/article-1-9544-en.html
_version_ 1818931790939684864
author S Mohammadi Jami
S Khafri
M Bahrami Feraydoni
author_facet S Mohammadi Jami
S Khafri
M Bahrami Feraydoni
author_sort S Mohammadi Jami
collection DOAJ
description BACKGROUND AND OBJECTIVE: Trigger finger is a condition in the finger that is locked in flexion or has a heterogeneous movement and is one of the most common causes of pain in the hand; the first line of treatment is the use of corticosteroids. Due to the fact that corticosteroid injection has side effects in diabetic patients, therefore, this study was performed to compare the results of injecting non-steroidal anti-inflammatory drugs (NSAIDs) as an alternative treatment instead of corticosteroid injection in trigger finger therapy. METHODS: This double-blind clinical trial study was performed on 84 patients with trigger finger referred to Shahid Beheshti Hospital in Babol which were divided in two equal groups of 42 individuals of injections of diclofenac and methylprednisolone. The severity of the disease was compared according to the Quinnell classification (with a score of 0-4) and the rate of improvement in the two groups in the first, third, sixth weeks and third, sixth and twelfth months. FINDINGS: The mean age in the diclofenac injection group was 52±9 years and in the prednisolone group was 53±7 years. There was no statistically significant difference between the two groups in terms of age, sex, presence of underlying disease, symptoms and duration of disease. The need for re-injection due to no improvement in symptoms was 34 patients (81%) in the diclofenac group and 20 patients (46%) in the methylprednisolone group (p=0.001). In the methylprednisolone group, the mean Quinnell rank was 1.4±0.8. The rate of recovery was higher in the methylprednisolone injection group than in the diclofenac group. From the beginning of the study to week 6th and from the beginning of the study to the 12th month, the improvement rate in the methylprednisolone injection group was significantly better than the diclofenac group (p=0.0001). CONCLUSION: The results of the study showed that both treatments are effective in improving the symptoms of trigger finger disease. But corticosteroid injections are associated with better and faster results in long-term and short-term studies.
first_indexed 2024-12-20T04:22:12Z
format Article
id doaj.art-c6b703eba5354925a58a51195e386fbe
institution Directory Open Access Journal
issn 1561-4107
2251-7170
language English
last_indexed 2024-12-20T04:22:12Z
publishDate 2020-03-01
publisher Babol University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
spelling doaj.art-c6b703eba5354925a58a51195e386fbe2022-12-21T19:53:37ZengBabol University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul1561-41072251-71702020-03-01221275282Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger FingerS Mohammadi Jami0S Khafri1M Bahrami Feraydoni2 1.Department of Orthopedic, School of Medicine, Babol University of Medical Sciences, Babol, I.R.Iran 2.Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran 1.Department of Orthopedic, School of Medicine, Babol University of Medical Sciences, Babol, I.R.Iran BACKGROUND AND OBJECTIVE: Trigger finger is a condition in the finger that is locked in flexion or has a heterogeneous movement and is one of the most common causes of pain in the hand; the first line of treatment is the use of corticosteroids. Due to the fact that corticosteroid injection has side effects in diabetic patients, therefore, this study was performed to compare the results of injecting non-steroidal anti-inflammatory drugs (NSAIDs) as an alternative treatment instead of corticosteroid injection in trigger finger therapy. METHODS: This double-blind clinical trial study was performed on 84 patients with trigger finger referred to Shahid Beheshti Hospital in Babol which were divided in two equal groups of 42 individuals of injections of diclofenac and methylprednisolone. The severity of the disease was compared according to the Quinnell classification (with a score of 0-4) and the rate of improvement in the two groups in the first, third, sixth weeks and third, sixth and twelfth months. FINDINGS: The mean age in the diclofenac injection group was 52±9 years and in the prednisolone group was 53±7 years. There was no statistically significant difference between the two groups in terms of age, sex, presence of underlying disease, symptoms and duration of disease. The need for re-injection due to no improvement in symptoms was 34 patients (81%) in the diclofenac group and 20 patients (46%) in the methylprednisolone group (p=0.001). In the methylprednisolone group, the mean Quinnell rank was 1.4±0.8. The rate of recovery was higher in the methylprednisolone injection group than in the diclofenac group. From the beginning of the study to week 6th and from the beginning of the study to the 12th month, the improvement rate in the methylprednisolone injection group was significantly better than the diclofenac group (p=0.0001). CONCLUSION: The results of the study showed that both treatments are effective in improving the symptoms of trigger finger disease. But corticosteroid injections are associated with better and faster results in long-term and short-term studies.http://jbums.org/article-1-9544-en.htmlnsaidcorticosteroidtrigger finger.
spellingShingle S Mohammadi Jami
S Khafri
M Bahrami Feraydoni
Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
nsaid
corticosteroid
trigger finger.
title Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
title_full Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
title_fullStr Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
title_full_unstemmed Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
title_short Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
title_sort comparison of methylprednisolone injection versus diclofenac injection in treatment of trigger finger
topic nsaid
corticosteroid
trigger finger.
url http://jbums.org/article-1-9544-en.html
work_keys_str_mv AT smohammadijami comparisonofmethylprednisoloneinjectionversusdiclofenacinjectionintreatmentoftriggerfinger
AT skhafri comparisonofmethylprednisoloneinjectionversusdiclofenacinjectionintreatmentoftriggerfinger
AT mbahramiferaydoni comparisonofmethylprednisoloneinjectionversusdiclofenacinjectionintreatmentoftriggerfinger